Abstract library

20 results for "Santos".
#1675 Abdominal Obesity, Fasting Glucose and Metabolic Syndrome Are Risk Factors for Well Differentiated Digestive Neuroendocrine Tumors
Introduction: Digestive NETs(DNETs)`s incidence has increased last 40 years. Visceral obesity and metabolic syndrome (MetSyn) were recently reported to be associated with several cancers, although not so far with DNET.
Conference: 14th Annual ENETS conference (2017)
Category: Epidemiology/Natural history/Prognosis - Descriptive epidemiology
Presenting Author: Dr. Ana Paula Santos
#194 Pancreatic Neuroendocrine Tumors: Experience of Endocrinology Department of the University Hospital of Coimbra
Introduction: Pancreatic neuroendocrine tumors (PNETs) are uncommon neoplasms, comprising 1-2% of all pancreatic tumors. The majority are nonfunctional. Of the functional tumors, insulinomas are the most common.
Conference: 8th Annual ENETS Conference (2011)
Category: Clinical
Presenting Author: Dr Alexandra Vieira
Authors: Vieira A, Santos J, Gomes L, Moreira A, ...
#273 The Succinate Dehydrogenase Genetic Testing in Patients with Extra-adrenal Paragangliomas: The Portuguese Cancer Center (Lisboa) Experience
Introduction: Extra-adrenal paragangliomas (PGLs) occur as sporadic or familial entities, the latter mostly in association with germline mutations of the SDHB, SDHC or SDHD genes.
Conference: 8th Annual ENETS Conference (2011)
Category: Basic
Presenting Author: Rita Domingues
#324 Well-differentiated Pancreatic Neuroendocrine Tumor of Uncertain Behavior: A Case Report
Introduction: A small number of Pancreatic Endocrine Tumors (PET) are well-differentiated tumors(WDET) showing benign or uncertain behavior. Prognosis mainly depends on the presence/absence of liver/bone metastasis.
Conference: 8th Annual ENETS Conference (2011)
Category: Clinical
Presenting Author: Dr. Joana Couto
#338 Pancreatic Endocrine Tumors: TNM staging and WHO Grading Relation with Prognosis
Introduction: Pancreatic endocrine tumors (PETs) are heterogeneous, rare neoplasms (large experience is unlikely). Prognostic stratification based on TNM staging and WHO grading is still under debate.
Conference: 8th Annual ENETS Conference (2011)
Category: Clinical
Presenting Author: Dra. Raquel G. Martins
#410 Pancreatic Neuroendocrine Tumors: Retrospective Analysis Of 44 Cases
Introduction: Neuroendocrine tumors (NETs) are heterogeneous neoplasms. Pancreatic NETs (pNETs) have a broad spectrum of features. Bioamines and peptides production distinguish functional from nonfunctional tumors.
Conference: 9th Annual ENETS Conference (2012)
Category: Clinical
Presenting Author: Mr. Pedro Marques
#673 MEN-1: Difficulties in Diagnosis and Therapeutic Dilemmas
Introduction: MEN1 is rare, and the most common mode of presentation is in previously identified kindred, but may be the propositus of a new kindred or a sporadic case.
Conference: 10th Annual ENETS Conference (2013)
Category: Basic Science - mTOR and other pathways, signalling, receptors
Presenting Author: Joana Saraiva
Authors: Saraiva J, Santos J, Moreno C, Alves M, ...
#734 Non-Functioning Neuroendocrine Pancreatic Neoplasia as an Incidental Finding–Surgery?
Introduction: The incidence of pancreatic non-functioning neuroendocrine neoplasms (PNF-NENs) has been increasing, mainly due to small incidentalomas. Pancreatic surgery complications are still responsible for significant morbidity.
Conference: 10th Annual ENETS Conference (2013)
Category: Surgical treatment
Presenting Author: Dr. Joana Couto
#960 Gastroenteropancreatic Neuroendocrine Neoplasms: The Experience of an Oncology Center
Introduction: Gastroenteropanceratic neuroendocrine neoplasms(GEP-NEN) are a heterogeneous group of tumors and an exponential increase in its incidence has been noticed over the past decades.
Conference: 11th Annual ENETS Conference (2014)
Category: Epidemiology/Natural history/Prognosis - Prognosis
Presenting Author: Dr. Joana Couto
#1025 Evaluation of Patients (pts) with Neuroendocrine Tumors at First Cardiological Consultation with Echocardiographic (Echo) Method. Argentum Group
Introduction: The incidence of carcinoid tumors is approximately 1 in 75,000 of the population of whom 50% develop carcinoid syndrome. Once carcinoid syndrome has developed, approximately 50% of these patients develop carcinoid heart disease which typically causes abnormalities in the right side of the heart.
Conference: 11th Annual ENETS Conference (2014)
Category: ...none of the below
Presenting Author: MD Daniel Santos